Page 22 - Read Online

Tummala et al. Vessel Plus 2022;6:17 https://dx.doi.org/10.20517/2574-1209.2021.114 Page 15 of 15

43. Dandale R, Rossi A, Onorati F, et al. Does aortic valve disease etiology predict postoperative atrial fibrillation in patients undergoing
aortic valve surgery? Future Cardiol 2014;10:707-15. DOI PubMed
44. Swinkels BM, de Mol BA, Kelder JC, Vermeulen FE, Ten Berg JM. New-onset postoperative atrial fibrillation after aortic valve
replacement: effect on long-term survival. J Thorac Cardiovasc Surg 2017;154:492-8. DOI PubMed
45. Filardo G, Hamilton C, Hamman B, Hebeler RF Jr, Adams J, Grayburn P. New-onset postoperative atrial fibrillation and long-term
survival after aortic valve replacement surgery. Ann Thorac Surg 2010;90:474-9. DOI PubMed
46. Furuta A, Lellouche N, Mouillet G, et al. Prognostic value of new onset atrial fibrillation after transcatheter aortic valve implantation: a
FRANCE 2 registry substudy. Int J Cardiol 2016;210:72-9. DOI PubMed
47. Yoon YH, Ahn JM, Kang DY, et al. Incidence, predictors, management, and clinical significance of new-onset atrial fibrillation after
transcatheter aortic valve implantation. Am J Cardiol 2019;123:1127-33. DOI PubMed
48. Lu F, Zhu SQ, Long X, et al. Clinical study of minimally invasive aortic valve replacement through a right parasternal second
intercostal transverse incision: the first Chinese experience. Asian J Surg 2021;44:1063-8. DOI PubMed
49. Maimari M, Baikoussis NG, Gaitanakis S, et al. Does minimal invasive cardiac surgery reduce the incidence of post-operative atrial
fibrillation? Ann Card Anaesth 2020;23:7-13. DOI PubMed PMC
50. Yokota J, Nishi H, Sekiya N, Yamada M, Takahashi T. Atrial fibrillation following aortic valve replacement: impact of perioperative
use of intravenous β-blocker. Gen Thorac Cardiovasc Surg 2017;65:194-9. DOI PubMed
51. Chopard R, Teiger E, Meneveau N, et al; FRANCE-2 Investigators. Baseline characteristics and prognostic implications of pre-
existing and new-onset atrial fibrillation after transcatheter aortic valve implantation: results from the FRANCE-2 registry. JACC
Cardiovasc Interv 2015;8:1346-55. DOI PubMed
52. Vora AN, Dai D, Matsuoka R, et al. Incidence, management, and associated clinical outcomes of new-onset atrial fibrillation following
transcatheter aortic valve replacement: an analysis from the STS/ACC TVT registry. JACC Cardiovasc Interv 2018;11:1746-56. DOI
PubMed
53. Nuis RJ, Van Mieghem NM, Schultz CJ, et al. Frequency and causes of stroke during or after transcatheter aortic valve implantation.
Am J Cardiol 2012;109:1637-43. DOI PubMed
54. Ruel M, Masters RG, Rubens FD, et al. Late incidence and determinants of stroke after aortic and mitral valve replacement. Ann
Thorac Surg 2004;78:77-83; discussion 83-4. DOI PubMed
55. Moonsamy P, Mohan N, Melnitchouk S. Optimal anticoagulation after tissue aortic and mitral valve replacement. Semin Thorac
Cardiovasc Surg 2020;32:197-201. DOI PubMed
56. Chakravarty T, Patel A, Kapadia S, et al. Anticoagulation after surgical or transcatheter bioprosthetic aortic valve replacement. J Am
Coll Cardiol 2019;74:1190-200. DOI PubMed
57. Vahanian A, Alfieri O, Andreotti F, et al; Joint Task Force on the Management of Valvular Heart Disease of the European Society of
Cardiology (ESC), European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart
disease (version 2012). Eur Heart J 2012;33:2451-96. DOI PubMed
58. Mérie C, Køber L, Skov Olsen P, et al. Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk
of mortality, thromboembolic complications, and bleeding. JAMA 2012;308:2118-25. DOI PubMed
59. Overtchouk P, Guedeney P, Rouanet S, et al. Long-term mortality and early valve dysfunction according to anticoagulation use: the
FRANCE TAVI registry. J Am Coll Cardiol 2019;73:13-21. DOI PubMed
60. Nijenhuis VJ, Brouwer J, Søndergaard L, Collet JP, Grove EL, Ten Berg JM. Antithrombotic therapy in patients undergoing
transcatheter aortic valve implantation. Heart 2019;105:742-8. DOI PubMed
61. Zeng Q, Cheng Z, Xia Y, et al. Optimal antithrombotic therapy after transcatheter aortic valve replacement in patients with atrial
fibrillation. Ther Adv Chronic Dis 2020;11:2040622320949068. DOI PubMed PMC
62. Guedeney P, Mehran R, Collet JP, Claessen BE, Ten Berg J, Dangas GD. Antithrombotic therapy after transcatheter aortic valve
replacement. Circ Cardiovasc Interv 2019;12:e007411. DOI PubMed
63. Gillinov AM, Bagiella E, Moskowitz AJ, et al; CTSN. Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N
Engl J Med 2016;374:1911-21. DOI PubMed PMC
64. Matos JD, Sellke FW, Zimetbaum P. Post-cardiac surgery atrial fibrillation: risks, mechanisms, prevention, and management. Card
Electrophysiol Clin 2021;13:133-40. DOI PubMed
65. Alkhouli M, Alqahtani F, Simard T, Pislaru S, Schaff HV, Nishimura RA. Predictors of use and outcomes of mechanical valve
replacement in the United States (2008-2017). J Am Heart Assoc 2021;10:e019929. DOI PubMed PMC